FRAIL-AF Study: More Bleeding With DOACs Compared With VKAs in Patients With Frailty?

Can J Cardiol. 2024 Aug;40(8):1377-1378. doi: 10.1016/j.cjca.2023.12.030. Epub 2024 Jan 2.

Authors

Alejandro Godoy¹, Noel C Chan², Vinai Bhagirath², John W Eikelboom², Jack Hirsh³

Affiliations

¹ Population Health Research Institute, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address: godoya1@mcmaster.ca.
² Population Health Research Institute, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
³ Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

PMID: 38176536
DOI: 10.1016/j.cjca.2023.12.030

No abstract available

Publication types

Letter
Editorial

MeSH terms

Aged
Aged, 80 and over
Anticoagulants / adverse effects
Anticoagulants / therapeutic use
Atrial Fibrillation* / complications
Atrial Fibrillation* / drug therapy
Factor Xa Inhibitors / adverse effects
Factor Xa Inhibitors / therapeutic use
Female
Frail Elderly
Frailty* / complications
Hemorrhage* / chemically induced
Humans
Male
Stroke / etiology
Stroke / prevention & control

Substances

Factor Xa Inhibitors
Anticoagulants